blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2506855

EP2506855 - ANTICANCER COMPOUNDS AND SCREENING METHOD [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.10.2014
Database last updated on 28.02.2026
Most recent event   Tooltip24.10.2014Application deemed to be withdrawnpublished on 26.11.2014  [2014/48]
Applicant(s)For all designated states
Harbor BioSciences, Inc.
9171 Towne Centre Drive, Suite 180
San Diego, CA 92122 / US
[2012/41]
Inventor(s)01 / FRINCKE, James, M.
6451 Merlin Drive
Carlsbad CA 92011 / US
 [2012/41]
Representative(s)Huenges, Martin
Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[N/P]
Former [2012/41]Huenges, Martin
Maiwald Patentanwalts GmbH
Elisenhof
Elisenstrasse 3
80335 München / DE
Application number, filing date10834064.730.11.2010
WO2010US58449
Priority number, dateUS20090266291P03.12.2009         Original published format: US 266291 P
US20090265294P30.11.2009         Original published format: US 265294 P
US20090266416P03.12.2009         Original published format: US 266416 P
US20090266483P03.12.2009         Original published format: US 266483 P
US20090266092P02.12.2009         Original published format: US 266092 P
[2012/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011066582
Date:03.06.2011
Language:EN
[2011/22]
Type: A1 Application with search report 
No.:EP2506855
Date:10.10.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 03.06.2011 takes the place of the publication of the European patent application.
[2012/41]
Search report(s)International search report - published on:US03.06.2011
(Supplementary) European search report - dispatched on:EP27.06.2014
ClassificationIPC:A61K31/56, C40B20/00, A61P35/00, C07J13/00, G01N33/74
[2014/31]
CPC:
A61K31/56 (EP,US); A61P35/00 (EP); A61P43/00 (EP);
C07J43/003 (EP,US); G01N33/5085 (EP,US); G01N33/743 (EP,US)
Former IPC [2012/41]A61K31/56, C40B20/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/41]
TitleGerman:ANTIKARZINOMVERBINDUNGEN UND SCREENINGVERFAHREN[2012/41]
English:ANTICANCER COMPOUNDS AND SCREENING METHOD[2012/41]
French:COMPOSÉS ANTICANCÉREUX ET PROCÉDÉ DE CRIBLAGE[2012/41]
Entry into regional phase28.06.2012National basic fee paid 
28.06.2012Search fee paid 
28.06.2012Designation fee(s) paid 
28.06.2012Examination fee paid 
Examination procedure28.06.2012Examination requested  [2012/41]
08.01.2013Amendment by applicant (claims and/or description)
03.06.2014Application deemed to be withdrawn, date of legal effect  [2014/48]
09.07.2014Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2014/48]
Fees paidRenewal fee
26.11.2012Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.11.201304   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y] US3050519  (JOSEF FRIED et al.) [Y] 1-13 * column 4, paragraph 2 *
 [Y] WO2009100258  (HOLLIS EDEN PHARMACEUTICALS et al.) [Y] 1-13 * claims 1-6,29-31 *
 [Y]   GYERMEK L ET AL: "STEROIDS. CCCX.1 STRUCTURE-ACTIVITY RELATIONSHIP OF SOME STEROIDAL HYPNOTIC AGENTS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 11, no. 1, 1 January 1968 (1968-01-01), pages 117 - 125, XP002070988, ISSN: 0022-2623, DOI: 10.1021/JM00307A026 [Y] 1-13 * page 125, column 2, paragraph 4 *

DOI:   http://dx.doi.org/10.1021/jm00307a026
International search[Y] US2008021006  (LARDY HENRY A et al.) [Y]
 [Y] US2006211059  (TANEJA SAMIR S et al.) [Y]
 [A] US2008221074  (FLORES-RIVEROS JAIME et al.) [A]
 [Y]   NEGRO-VILAR.: "Selective Androgen Receptor Modulators (SARMs): A Novel Approach to Androgen Therapy for the New Millennium.", J. CLIN. ENDOCRINOL. METAB., vol. 84, 1999, pages 3459 - 3462, XP002193249 [Y]

DOI:   http://dx.doi.org/10.1210/jc.84.10.3459
 [A]   OFFNER ET AL.: "An Orally Bioavaifabfe Synthetic Analog of an Active Dehydroepiandrosterone Metabolite Reduces Established Disease in Rodent Models of Rheumatoid Arthritis.", THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 329, no. 3, 2009, pages 1100 - 1109, XP055025351 [A]

DOI:   http://dx.doi.org/10.1124/jpet.108.145086
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.